If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
incident vertebral fractures, and
incident nonvertebral fractures (Table 1) (Forteo Package Insert, 2012).
Teriparatide was effective in reducing the risk for vertebral fractures regardless of age, baseline rate of bone turnover, or baseline BMD (Forteo Package Insert, 2012).
ap<.001 compared to placebo
bp<.05 compared to placebo
Enclosed Prescribing Information
The published references below are available upon request by contacting 1-800-LillyRx.
FORTEO® [Package Insert]. Indianapolis, IN: Eli Lilly and Company; 2012.
Date of Last Review: February 12, 2017